Cellular Engineering Technologies, Inc. (CET) provides optimized reagents and human cell lines that address the technical and clinical challenges of developing next-generation cell therapies and regenerative medicines. We offer human recombinant growth factors and cytokines that are designed to generate maximum cellular response and bioavailability. Our portfolio of iPSC Solutions provides cell reprogramming kits that allow researchers to generate iPSC colonies safely and efficiently in-house and our iPSC Growth Media generates best-in-class cell expansion and viability for your R&D budget. Our portfolio of human somatic stem cells and induced pluripotent stem cells, programmed using our patented virus and oncogene-free methods, produce the safest and most scalable starting cell line for your research and manufacturing needs.